- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04618536
Comparison of Sun Protection Factor 30 Persistence Between Inorganic and Organic Sunscreen in Swimmer
November 21, 2020 updated by: Shannaz Nadia Yusharyahya
Prolonged sunlight exposure in swimming athletes can cause various changes in the skin; among them is sunburn.
The use of sunscreen can reduce sunburn effectively.
However, various types of physical activity that can trigger sweating, friction, washing with water, or sun exposure after sunscreen use can interfere with its effectiveness in the form of a decreased SPF level.
The purpose of this study is to determine and compare the persistence of organic and inorganic sun protection factor 30 (SPF 30) sunscreens after 1.5 hours of swimming.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia, 10430
- Cipto Mangunkusumo hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Female or male swimming athletes aged 18-40 years.
- Practice swimming at least 3 times a week with a duration of 1.5-2 hours per practice in the morning or afternoon.
- Willing to be the subject of research by signing the consent.
- Do not have skin diseases.
- Do not have a history of allergies to sunscreens.
Exclusion Criteria:
- Existence of skin lesion in the test area.
- In the treatment of phototherapy.
- Using drugs with photosensitivity side effects.
- History of skin malignancy, history of photosensitivity reactions or history of disease affected by UV rays.
- Exposure to direct sunlight to the test area 24 hours before the study and during the study period.
- Absence of erythema response 24 hours after the radiation test.
- Erythema occurs in the entire test area box 24 hours after the radiation test.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Inorganic sunscreen
|
Organic sunscreen will be applied evenly to 2 areas on the back of the subject with a 1 cc syringe and gloved finger in an amount of 2 mg / cm2.
In the first session, one area will be irradiated 20 minutes after sunscreen application.
In the second session, the other area will be irradiated after the subject has swam for 1.5 hours.
|
|
Experimental: Organic sunscreen
|
Inorganic sunscreen will be applied evenly to 2 areas on the back of the subject with a 1 cc syringe and gloved finger in an amount of 2 mg / cm2.
In the first session, one area will be irradiated 20 minutes after sunscreen application.
In the second session, the other area will be irradiated after the subject has swam for 1.5 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SPF change after swimming for 1.5 hours
Time Frame: 24 hours
|
SPF of inorganic and organic sunscreen were calculated before and after swimming.
The difference between SPF before and after swimming will be calculated and compared between the organic and inorganic group.
SPF were calculated using minimal erythemal dose (MED) test.
The test itself will be conducted in 2 days.
Irradiation will be conducted on the first day and minimal erythemal dose result will be collected 24 hours after the irradiation.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inorganic sunscreen SPF
Time Frame: 24 hours
|
SPF resulted from in vivo method, conducted before swimming.
SPF were calculated using MED test.
The test itself will be conducted in 2 days.
Irradiation will be conducted on the first day and MED result will be collected 24 hours after the irradiation.
|
24 hours
|
|
Organic sunscreen SPF
Time Frame: 24 hours
|
SPF resulted from in vivo method, conducted before swimming.
SPF were calculated using minimal erythemal dose test.
The test itself will be conducted in 2 days.
Irradiation will be conducted on the first day and minimal erythemal dose result will be collected 24 hours after the irradiation.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karin Rachmani, MD, Indonesia University
- Principal Investigator: Shannaz N Yusharyahya, MD, PhD, Indonesia University
- Principal Investigator: Adhimukti T Sampurna, MD, Indonesia University
- Principal Investigator: Respati W Ranakusuma, MD, PhD, Indonesia University
- Principal Investigator: Sandra Widaty, MD, PhD, Indonesia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 5, 2020
Primary Completion (Anticipated)
December 5, 2020
Study Completion (Anticipated)
January 31, 2021
Study Registration Dates
First Submitted
November 1, 2020
First Submitted That Met QC Criteria
November 1, 2020
First Posted (Actual)
November 6, 2020
Study Record Updates
Last Update Posted (Actual)
November 24, 2020
Last Update Submitted That Met QC Criteria
November 21, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-09-1037
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sunscreen Persistence
-
Bispebjerg HospitalUnknownSunscreen Persistence | Vitamin D Production in the SkinDenmark
-
Bispebjerg HospitalCompletedQuantity of Sunscreen | Sun Protection Factor | Sun Safety Campaigns | Sunscreen UseDenmark
-
Venus Research CenterEnrolling by invitationSun Exposure | Sunscreen Agents | Sun Damaged Skin | Photoprotection | SunscreenEgypt
-
Indonesia UniversityPT Paragon Technology and InnovationCompleted
-
BayerCompletedSunscreen AgentsUnited States
-
BayerCompletedSunscreen AgentsUnited States
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSunscreenUnited States
Clinical Trials on Organic sunscreen
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSunscreenUnited States
-
Pierre Fabre Dermo CosmetiqueCompletedAtopic Dermatitis (AD) | SCORAD Index(15-25)Mauritius
-
Kenvue Brands LLCCompleted
-
Pierre Fabre Dermo CosmetiqueCompletedAtopic Dermatitis (AD) | SCORAD Index (15-25)Mauritius
-
Sun Protection FoundationEnrolling by invitationSunburn | Sun Damaged Skin | Overexposure to Sun RaysUnited States, Chile, Peru
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
BayerCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed